neostigmine has been researched along with Lipidoses in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradley, WG | 1 |
| Jenkison, M | 1 |
| Park, DC | 1 |
| Hudgson, P | 1 |
| Gardner-Medwin, D | 1 |
| Pennington, RJ | 1 |
| Walton, JN | 1 |
1 other study available for neostigmine and Lipidoses
| Article | Year |
|---|---|
A myopathy associated with lipid storage.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol; Chromatography, Thin Layer; C | 1972 |